| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 14, 2007
From the Department of Physiology and Pharmacology (A-M.H., L.E.R., P.B.L.H., S.S.N., O.S., B.L.J.), University of Southern Denmark, Odense, Denmark; Institute of Clinical Pharmacology (R.M.N.), Johann Wolfgang Goethe-University, Frankfurt, Germany; Department of Pharmacology (P.V.), University of Hong Kong, Hong Kong; and the Department of Pharmacology (S.N.), Kyoto University Faculty of Medicine, Kyoto, Japan. * To whom correspondence should be addressed. E-mail: bljensen{at}health.sdu.dk.
Abstract--The present experiments were designed to test the hypothesis that prostaglandin (PG) E2 causes vasodilatation through activation of endothelial NO synthase (eNOS). Aortic rings from mice with targeted deletion of eNOS and E-prostanoid (EP) receptors were used for contraction studies. Blood pressure changes in response to PGE2 were measured in conscious mice. Single doses of PGE2 caused concentration-dependent relaxations during contractions to phenylephrine (EC50=5*10-8 mol/L). Relaxation after PGE2 was absent in rings without endothelium and in rings from eNOS-/- mice and was abolished by NG-nitro-L-arginine methyl ester and the soluble guanylate cyclase inhibitor 1H1,2,4-oxadiazolo-[4,3-a]quinoxalin-1-one. In PGE2-relaxed aortic rings, the cGMP content increased significantly. PGE2-induced relaxations were abolished by the EP4 receptor antagonist AE3-208 (10-8 mol/L) and mimicked by an EP4 agonist (AE1-329, 10-7 mol/L) in the presence of endothelium and eNOS only. Relaxations were attenuated significantly in rings from EP4-/- mice but normal in EP2-/-. Inhibitors of the cAMP-protein kinase A pathway attenuated, whereas the inhibitor of protein phosphatase 1C, calyculin (10-8 mol/L), abolished the PGE2-mediated relaxation. In aortic rings, PGE2 dephosphorylated eNOS at Thr495. Chronically catheterized eNOS-/- mice were hypertensive (137±3.6 mm Hg, n=13, versus 101±3.9 mm Hg, n=9) and exhibited a lower sensitivity of blood pressure reduction in response to PGE2 compared with wild-type mice. There was no difference in the blood pressure response to nifedipine. These findings show that PGE2 elicits EP4 receptor-mediated, endothelium-dependent stimulation of eNOS activity by dephosphorylation at Thr495 resulting in guanylyl cyclase-dependent vasorelaxation and accumulation of cGMP in aortic rings.
Revised on March 12, 2007
Prostaglandin E2 Induces Vascular Relaxation by E-Prostanoid 4 Receptor-Mediated Activation of Endothelial Nitric Oxide Synthase
Ana-Marija Hristovska;
This article has been cited by other articles:
![]() |
T. Dalsgaard, C. Kroigaard, T. Bek, and U. Simonsen Role of Calcium-Activated Potassium Channels with Small Conductance in Bradykinin-Induced Vasodilation of Porcine Retinal Arterioles Invest. Ophthalmol. Vis. Sci., August 1, 2009; 50(8): 3819 - 3825. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Di Francesco, L. Totani, M. Dovizio, A. Piccoli, A. Di Francesco, T. Salvatore, A. Pandolfi, V. Evangelista, R. A. Dercho, F. Seta, et al. Induction of Prostacyclin by Steady Laminar Shear Stress Suppresses Tumor Necrosis Factor-{alpha} Biosynthesis via Heme Oxygenase-1 in Human Endothelial Cells Circ. Res., February 27, 2009; 104(4): 506 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Jia, X. Guo, H. Zhang, M.-H. Wang, Z. Dong, and T. Yang Microsomal Prostaglandin Synthase-1-Derived Prostaglandin E2 Protects Against Angiotensin II-Induced Hypertension via Inhibition of Oxidative Stress Hypertension, November 1, 2008; 52(5): 952 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H.C. Tang, B. L. Jensen, O. Skott, G. P.H. Leung, M. Feletou, R. Y.K. Man, and P. M. Vanhoutte The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats Cardiovasc Res, April 1, 2008; 78(1): 130 - 138. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |